10.1016/j.peptides.2012.06.014 [DOI] [PubMed] [Google Scholar] 78.Ahmad S, Wang L, Ward PE
According to current study findings, the guideline from ADA 2023 has designated SGLT-2i and GLP-1 RAs as first-line drugs for T2DM patients with established ASCVD or high cardiovascular risk, and metformin is no longer recommended as first-line therapy for T2DM patients with high cardiovascular risk due to its neutral HF benefits
These drugs mimic a naturally occurring hormone called GLP-1, crucial in regulating blood sugar levels, appetite, and digestion
Oral hydrolyzed collagen and oral hyaluronic acid are well tolerated, and numerous clinical trials show they can mitigate some signs of skin aging
AIDEVI WhiteAura Science is built around a simple 3-step framework: help regulate tyrosinase activity, discourage melanin transfer, and support the fading of existing visible dark spots
Sixty-three percent of GLP-1 users said they've had fewer alcohol or drug-related relapses since starting their medication